Investigating the progression of heart disease in diverse populations
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS
This study is looking at heart health in a diverse group of men and women aged 45-84 who don’t have any symptoms, using tests like CT scans and MRIs to spot early signs of heart disease and understand how it develops over time.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11292459 on NIH RePORTER |
What this research studies
The Multi-Ethnic Study of Atherosclerosis (MESA) examines the early signs and risk factors of cardiovascular disease in a diverse group of men and women aged 45-84 who initially showed no symptoms. Participants undergo various imaging tests and assessments, including CT scans and MRIs, to evaluate their heart and blood vessel health. The study aims to track changes over time and identify predictors of heart disease, providing valuable insights into how this condition develops across different ethnic groups. By continuously following participants for clinical events, the research seeks to enhance understanding of cardiovascular health.
Who could benefit from this research
Good fit: Ideal candidates for this research are men and women aged 45-84 with no prior evidence of clinical cardiovascular disease.
Not a fit: Patients who are younger than 45 or those with existing cardiovascular disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for cardiovascular disease tailored to diverse populations.
How similar studies have performed: Previous studies on cardiovascular health in diverse populations have shown promising results, indicating that this approach is both relevant and necessary.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Watson, Karol E — University of California Los Angeles
- Study coordinator: Watson, Karol E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.